HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synthesis and evaluation of multisubstrate bicyclic pyrimidine nucleoside inhibitors of human thymidine phosphorylase.

Abstract
A series of novel, multisubstrate, bicyclic pyrimidine nucleoside inhibitors of human thymidine phosphorylase (TP) is described. Thymidine phosphorylase has been implicated in angiogenesis and plays a significant role in tumor progression and metastasis. The presence and orientation of the phosphonate moiety (acting as a phosphate mimic) in these derivatives were critical for inhibitory activity. The most active compounds possessed a phosphonate group in an endo orientation. This was consistent with molecular modeling results that showed the endo isomer protein-ligand complex to be lower in energy than the exo complex.
AuthorsAmy L Allan, Patricia L Gladstone, Melissa L P Price, Stephanie A Hopkins, Jose C Juarez, Fernando Doñate, Robert J Ternansky, David E Shaw, Bruce Ganem, Yingbo Li, Weiru Wang, Steven Ealick
JournalJournal of medicinal chemistry (J Med Chem) Vol. 49 Issue 26 Pg. 7807-15 (Dec 28 2006) ISSN: 0022-2623 [Print] United States
PMID17181163 (Publication Type: Evaluation Study, Journal Article)
Chemical References
  • Bridged Bicyclo Compounds, Heterocyclic
  • Enzyme Inhibitors
  • Pyrimidine Nucleosides
  • Thymidine Phosphorylase
Topics
  • Bridged Bicyclo Compounds, Heterocyclic (chemical synthesis, chemistry, pharmacology)
  • Enzyme Inhibitors (chemical synthesis, chemistry, pharmacology)
  • Humans
  • Models, Molecular
  • Molecular Structure
  • Pyrimidine Nucleosides (chemical synthesis, chemistry, pharmacology)
  • Structure-Activity Relationship
  • Thymidine Phosphorylase (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: